WEST PHARMACEUTICAL SERVICES, INC. Restructuring Reserve, Period Expense (Deprecated 2012-01-31)
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Restructuring Reserve, Period Expense (Deprecated 2012-01-31) of $400.00 thousand for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-04.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringReservePeriodExpense · last filed 2012-05-04
- WEST PHARMACEUTICAL SERVICES, INC. restructuring reserve, period expense (deprecated 2012-01-31) for the quarter ending 2012-03-31 was $400.00K.
- WEST PHARMACEUTICAL SERVICES, INC. restructuring reserve, period expense (deprecated 2012-01-31) for the quarter ending 2011-12-31 was $2.00M.
- WEST PHARMACEUTICAL SERVICES, INC. restructuring reserve, period expense (deprecated 2012-01-31) for the quarter ending 2011-09-30 was $800.00K.
- WEST PHARMACEUTICAL SERVICES, INC. restructuring reserve, period expense (deprecated 2012-01-31) for fiscal 2011 was $5.30M, a 50.00% decline from fiscal 2010.
- WEST PHARMACEUTICAL SERVICES, INC. restructuring reserve, period expense (deprecated 2012-01-31) for fiscal 2010 was $10.60M.
| Period end | Restructuring Reserve, Period Expense (Deprecated 2012-01-31) 3 month | Restructuring Reserve, Period Expense (Deprecated 2012-01-31) 6 month | Restructuring Reserve, Period Expense (Deprecated 2012-01-31) 9 month | Restructuring Reserve, Period Expense (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|
| 2012-03-31 | $400.00K 10-Q · filed 2012-05-04 | $2.40M derived: sum of 2 quarters · filed 2012-05-04 | $3.20M derived: sum of 3 quarters · filed 2012-05-04 | |
| 2011-12-31 | $2.00M derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-03-01 | $2.80M derived: sum of 2 quarters · filed 2012-03-01 | $5.30M 10-K/A · filed 2012-03-01 | |
| 2011-09-30 | $800.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-07 | $3.30M 10-Q · filed 2011-11-07 | ||
| 2011-06-30 | $2.50M 10-Q/A · filed 2011-08-08 | |||
| 2010-12-31 | $10.60M 10-K/A · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |